FIELD: chemistry.
SUBSTANCE: invention relates to a new derivative of pyroglutamic acid - (2S,4S)-4-amino-N-(4-fluorophenyl)pyroglutamic acid by the formula 1.
EFFECT: production of a new compound applicable as a cerebral protector with nootropic and antithrombotic activity.
1 cl, 6 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
4-(4-ACETOXYBENZOYLAMINO)BUTANOYLGLYCINE, WHICH HAS A CEREBROPROTECTIVE ACTION IN CEREBRAL ISCHEMIA | 2017 |
|
RU2657820C1 |
4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
N-(ACETYLSALICYLOYL)PYRAZOL WITH CEREBROPROTECTOR ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2016 |
|
RU2632005C1 |
NEW WATER-SOLUBLE SALICYLAMIDE DERIVATIVE WITH NEUROPROTECTIVE ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2017 |
|
RU2641102C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
POTASSIUM N-(4-ACETOXYBENZOYL)GLYCINATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2556637C1 |
NOVEL N-SULPHANILAMIDE DERIVATIVE OF PYRIMIDIN-4(1H)-ONE, HAVING CEREBROPROTECTIVE ACTIVITY FOR TREATING CHRONIC TRAUMATIC ENCEPHALOPATHY | 2019 |
|
RU2711613C1 |
BASIC MAGNESIUM SALT OF N-(4-ACETOXYBENZOYL)GLYCINE HAVING CEREBROPROTECTIVE ACTION | 2014 |
|
RU2570204C1 |
DERIVATIVE OF 3-HYDROXYPYRIDINE WITH ANXIOLYTIC AND NOOTROPIC EFFECT | 2017 |
|
RU2664453C1 |
Authors
Dates
2022-04-01—Published
2021-02-17—Filed